Global Subcutaneous Biologics Market Report By Application By Subcutaneous Drug Delivery Systems (Prefilled Syringes, Wearable Injectors, Auto-injectors, Drug Reconstitution Delivery Systems), By Applications (Crohn’s Disease, Rheumatoid Arthritis, Breast Cancer, Leukemia, Lymphoma, Psoriasis) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11214386
April 2021
Report Formats:
Global Subcutaneous Biologics Market Overview

The key driver impacting the subcutaneous biologics market is the growing prevalence of rheumatoid arthritis, breast cancer, and Crohn's diseases globally. For instance, the World Cancer Research Fund reports estimations; Breast cancer is the most common cancer occurring in women globally. In 2012   around 1.7 million new cases have been diagnosed, accounting for 25 percent of all cancers in women. It is 2018; it increased to 2.1 million newly diagnosed female breast cancer cases in 2018. As per the Center for Disease Control and Prevention, In 2015, an expected 1.3% of U.S. adults (3 million) were being diagnosed with IBD (either Crohn's disease or ulcerative colitis). It was a significant rise from 1999 (0.9% or 2 million adults). Moreover, the Introduction of innovative drug delivery devices such as auto-injectors and prefilled syringes is estimated to be a significant factor contributing to market growth.
According to Value Market Research, the global subcutaneous biologics market size was valued at around USD 122.5 billion in 2020 and is projected to grow at a CAGR of about 12.5% during the forecast period of 2021 to 2027.

The subcutaneous administration route offers significant advantages over intravenous administration is estimated to augment subcutaneous biologics demand in the forecast period. For instance, such as easiness of drug administration does not necessitate skilled personnel for drug administration, facilitate at-home drug delivery, decrease patient time at healthcare facilities, condense medicine costs, and augment therapy compliance. Growing cases for rheumatoid arthritis(RA) are likely to create more demand for subcutaneous biologics in the coming years. As per the Rheumatoid Arthritis organization, RA is a chronic disease that affects around 1.3 million Americans and approximately 1% of the global population. It is expected that over 300,000 children in the United States undergo juvenile RA. However, the high risk of allergic reactions may hamper the global subcutaneous biologics market in the long run. Also, the strict regulatory requirement for subcutaneous biologics' approval is negatively impacting the market growth in the forecast period. The current industry trends, such as the rising trend of self-medication, expanding biosimilars market, are expected to provide market players with new market opportunities.

The subcutaneous biologics market is vast, with many local and global players. The key leaders follow different strategies to advance their market position, such as contracts, amalgamation, getting biologics license from regulatory authorities(FDA), extending product portfolio, acquisitions, and product upgrades to raise their market share across the globe. For instance, in July 2018, Halozyme Therapeutics, Inc. declared that the U.S. Food and Drugs Administration (FDA) acknowledged a biologics license from 'Genentech,' a Roche Group member, for the subcutaneous formulation of trastuzumab (Herceptin). It is the company's FDA-approved indication for the treatment of breast cancer. The major players in the report are Biogen Idec, Amgen, Inc., Genentech Inc., F. Hoffmann-La Roche AG, AbbVie, Inc., Eisai, Inc., Takeda Pharmaceutical Company Ltd., Pfizer Ltd., and Bristol-Myers Squibb.

Global Subcutaneous Biologics Market

In this research report, the subcutaneous biologics market is segmented by subcutaneous drug delivery systems, applications, and regions.

Analysis by Subcutaneous Drug Delivery Systems:
 By subcutaneous drug delivery systems, the report is categorized into prefilled syringes, wearable injectors, auto-injectors, and drug reconstitution delivery systems, and others. The prefilled syringes segment dominates the subcutaneous drug delivery systems segment with over 20% share in 2020. It is a highly effective biologics and drug administration routes such as proteins, antibodies, peptides, and other large and complex molecules. Moreover, the increasing trend of self-medication and requirement of high concentration subcutaneous formulation of biologics driving demand for prefilled syringes in the forecast period. 

Analysis by Applications:
By applications, the report is categorized into Crohn's diseases, rheumatoid arthritis, breast cancer, leukemia, lymphoma, and psoriasis. The Crohn’s disease segment dominates the application segment with over 25% share in 2020. It is due to the growing cases of Crohn’s disease globally. Moreover, the High adoption rate of viscous biologics in treating chronic conditions with increasing awareness about the benefits of biologics over other treatment methods contributes to the high market demand for Crohn's disease treatment in the forecast period.

Analysis by Region:
In the regional outlook of the global subcutaneous biologics market, the North America region dominates with a 30% market share during the forecast period. It is due to the high prevalence of rheumatoid arthritis and breast cancer across the United States and Canada. Also, Canada has the most increased occurrence of Crohn's across the globe. Moreover, the rising healthcare expenditure and high adoption rate and approval of biologics by the U.S. Food and Drugs Administration (FDA) contribute to the development of the subcutaneous biologics market in North America.
 
Market Segmentation covered in the Report:
By Subcutaneous Drug Delivery Systems
  • Prefilled Syringes
  • Wearable Injectors
  • Auto-injectors
  • Drug Reconstitution Delivery Systems.
 
By Applications
  • Crohn’s Disease
  • Rheumatoid Arthritis
  • Breast Cancer
  • Leukemia
  • Lymphoma
  • Psoriasis
 
By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

METHODOLOGY

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications. 

If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.   

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . SUBCUTANEOUS BIOLOGICS – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Subcutaneous Drug Delivery Systems
           3.7.2 By Applications
           3.7.3 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL SUBCUTANEOUS BIOLOGICS MARKET ANALYSIS BY SUBCUTANEOUS DRUG DELIVERY SYSTEMS
       6.1 Overview by Subcutaneous Drug Delivery Systems
       6.2 Historical and Forecast Data
       6.3 Analysis by Subcutaneous Drug Delivery Systems
       6.4 Prefilled Syringes Market by Regions
       6.6 Wearable Injectors Market by Regions
       6.5 Auto-injectors Market by Regions
       6.7 Drug Reconstitution Delivery Systems. Market by Regions
 
7 . GLOBAL SUBCUTANEOUS BIOLOGICS MARKET ANALYSIS BY APPLICATIONS
       7.1 Overview by Applications
       7.2 Historical and Forecast Data
       7.3 Analysis by Applications
       7.4 Crohn’s Disease Market by Regions
       7.5 Rheumatoid Arthritis Market by Regions
       7.6 Breast Cancer Market by Regions
       7.7 Leukemia Market by Regions
       7.8 Lymphoma Market by Regions
       7.9 Psoriasis Market by Regions
 
8 . GLOBAL SUBCUTANEOUS BIOLOGICS MARKET ANALYSIS BY GEOGRAPHY
       8.1. Regional Outlook
       8.2. Introduction
       8.3. North America
           8.3.1. Overview, Historic and Forecast Data
           8.3.2. North America By Segment
           8.3.3. North America By Country
           8.3.4. United State
           8.3.5. Canada
           8.3.6. Mexico
       8.4. Europe
           8.4.1. Overview, Historic and Forecast Data
           8.4.2. Europe by Segment
           8.4.3. Europe by Country
           8.4.4. United Kingdom
           8.4.5. France
           8.4.6. Germany
           8.4.7. Italy
           8.4.8. Russia
           8.4.9. Rest Of Europe
       8.5. Asia Pacific
           8.5.1. Overview, Historic and Forecast Data
           8.5.2. Asia Pacific by Segment
           8.5.3. Asia Pacific by Country
           8.5.4. China
           8.5.5. India
           8.5.6. Japan
           8.5.7. South Korea
           8.5.8. Australia
           8.5.9. Rest Of Asia Pacific
       8.6. Latin America
           8.6.1. Overview, Historic and Forecast Data
           8.6.2. Latin America by Segment
           8.6.3. Latin America by Country
           8.6.4. Brazil
           8.6.5. Argentina
           8.6.6. Peru
           8.6.7. Chile
           8.6.8. Rest of Latin America
       8.7. Middle East & Africa
           8.7.1. Overview, Historic and Forecast Data
           8.7.2. Middle East & Africa by Segment
           8.7.3. Middle East & Africa by Country
           8.7.4. Saudi Arabia
           8.7.5. UAE
           8.7.6. Israel
           8.7.7. South Africa
           8.7.8. Rest Of Middle East And Africa
 
9 . COMPETITIVE LANDSCAPE OF THE SUBCUTANEOUS BIOLOGICS COMPANIES
       9.1. Subcutaneous Biologics Market Competition
       9.2. Partnership/Collaboration/Agreement
       9.3. Merger And Acquisitions
       9.4. New Product Launch
       9.5. Other Developments
 
10 . COMPANY PROFILES OF SUBCUTANEOUS BIOLOGICS INDUSTRY
       10.1. Company Share Analysis
       10.2. Market Concentration Rate
       10.3. Biogen Idec
           10.3.1. Company Overview
           10.3.2. Financials
           10.3.3. Products
           10.3.4. Recent Developments
       10.4. Amgen, Inc.
           10.4.1. Company Overview
           10.4.2. Financials
           10.4.3. Products
           10.4.4. Recent Developments
       10.5. Genentech Inc.
           10.5.1. Company Overview
           10.5.2. Financials
           10.5.3. Products
           10.5.4. Recent Developments
       10.6. F. Hoffmann-La Roche AG
           10.6.1. Company Overview
           10.6.2. Financials
           10.6.3. Products
           10.6.4. Recent Developments
       10.7. AbbVie, Inc.
           10.7.1. Company Overview
           10.7.2. Financials
           10.7.3. Products
           10.7.4. Recent Developments
       10.8. Eisai, Inc.
           10.8.1. Company Overview
           10.8.2. Financials
           10.8.3. Products
           10.8.4. Recent Developments
       10.9. Takeda Pharmaceutical Company Ltd.
           10.9.1. Company Overview
           10.9.2. Financials
           10.9.3. Products
           10.9.4. Recent Developments
       10.10. Pfizer Ltd.
           10.10.1. Company Overview
           10.10.2. Financials
           10.10.3. Products
           10.10.4. Recent Developments
       10.11. Bristol-Myers Squibb
           10.11.1. Company Overview
           10.11.2. Financials
           10.11.3. Products
           10.11.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Subcutaneous Drug Delivery Systems (USD MN)
  •  Prefilled Syringes Market by Geography (USD MN)
  •  Wearable Injectors Market by Geography (USD MN)
  •  Auto-injectors Market by Geography (USD MN)
  •  Drug Reconstitution Delivery Systems. Market by Geography (USD MN)
  •  Analysis Market by Applications (USD MN)
  •  Crohn’s Disease Market by Geography (USD MN)
  •  Rheumatoid Arthritis Market by Geography (USD MN)
  •  Breast Cancer Market by Geography (USD MN)
  •  Leukemia Market by Geography (USD MN)
  •  Lymphoma Market by Geography (USD MN)
  •  Psoriasis Market by Geography (USD MN)
  •  Global Subcutaneous Biologics Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Subcutaneous Biologics Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Subcutaneous Biologics Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Subcutaneous Drug Delivery Systems
  •  Market Attractiveness Analysis by Applications
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Subcutaneous Drug Delivery Systems (USD MN)
  •  Prefilled Syringes Market by Geography (USD MN)
  •  Wearable Injectors Market by Geography (USD MN)
  •  Auto-injectors Market by Geography (USD MN)
  •  Drug Reconstitution Delivery Systems. Market by Geography (USD MN)
  •  Global Market Analysis by Applications (USD MN)
  •  Crohn’s Disease Market by Geography (USD MN)
  •  Rheumatoid Arthritis Market by Geography (USD MN)
  •  Breast Cancer Market by Geography (USD MN)
  •  Leukemia Market by Geography (USD MN)
  •  Lymphoma Market by Geography (USD MN)
  •  Psoriasis Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials